Skip to content

Drug interactions

Amisulpride + Buprenorphine transdermal

Severity: Major

Amisulpride and Buprenorphine transdermal: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Transdermal buprenorphine can prolong the QT interval, and amisulpride has a dose-related QT effect. Both also cause sedation, so combined use may add to arrhythmia risk and CNS depression.

What this interaction means in plain words

Amisulpride and Buprenorphine transdermal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive QT prolongation and CNS depression.

What to do

Check a baseline ECG and electrolytes and monitor QTc and sedation. Use the lowest effective doses, and prefer an alternative if QT risk factors are present.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amisulpride and Buprenorphine transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Amisulpride with Buprenorphine transdermal?

MediHelp rates the interaction as major. Amisulpride and Buprenorphine transdermal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Transdermal buprenorphine can prolong the QT interval, and amisulpride has a dose-related QT effect. Both also cause sedation, so combined use may add to arrhythmia risk and CNS depression.

How serious is the interaction between Amisulpride and Buprenorphine transdermal?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check a baseline ECG and electrolytes and monitor QTc and sedation. Use the lowest effective doses, and prefer an alternative if QT risk factors are present.

What other medicines interact with Amisulpride?

MediHelp also lists interactions of Amisulpride with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Amisulpride page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in